News

With the deal, Sanofi gains Blueprint’s portfolio of rare immunological disease treatments, including systemic mastocytosis ...
Sanofi SNY announced that it has entered into a definitive agreement to acquire Blueprint Medicines BPMC for a total deal ...
Shares of Blueprint Medicines Corporation (BPMC) traded 26% higher in pre-market on Monday after French pharmaceutical ...
Azul files for Chapter 11, strikes restructuring deal with key stakeholders, including United and American Airlines ...
A version of this article appeared in the May–June 2023 issue of Harvard Business Review. Jill Avery is a senior lecturer of business administration and the C. Roland Christensen Distinguished ...